Global ENT Surgical Devices Market Growth (Status and Outlook) 2023-2029
ENT surgery is one of the most elaborate fields of surgical specialty services, using advanced technology and a broad range of procedures that also includes major reconstructive surgery to correct deformity or injury.
LPI (LP Information)' newest research report, the “ENT Surgical Devices Industry Forecast” looks at past sales and reviews total world ENT Surgical Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected ENT Surgical Devices sales for 2023 through 2029. With ENT Surgical Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ENT Surgical Devices industry.
This Insight Report provides a comprehensive analysis of the global ENT Surgical Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on ENT Surgical Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global ENT Surgical Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for ENT Surgical Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global ENT Surgical Devices.
The global ENT Surgical Devices market size is projected to grow from US$ 2900.9 million in 2022 to US$ 4518.5 million in 2029; it is expected to grow at a CAGR of 6.5% from 2023 to 2029.
Medtronic, J&J (Acclarent), Stryker, Smith & Nephewetc, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
North America is the largest consumption place, with a sales revenue market share nearly 40%. Following North America, Europe is the second largest consumption place with the sales revenue market share of over 30%.
The classification of ENT surgical devices includes powered surgical instruments, radiofrequency (RF) hand pieces, handheld instruments and others. The proportion of powered surgical instruments is about 27%, and the proportion of radiofrequency (RF) hand pieces is about 50%.
ENT surgical devices are widely used though hospital and clinic. The proportion of ENT surgical devices used in clinic is about 60%.
This report presents a comprehensive overview, market shares, and growth opportunities of ENT Surgical Devices market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Powered Surgical Instruments
Radiofrequency (RF) Hand Pieces
Handheld Instruments
Others
Segmentation by application
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
J & J (Acclarent)
Stryker
Smith & Nephew
Olympus
B. Braun
Karl Storz
Spiggle &Theis
Conmed
Otopront
REDA
Tiansong
Jiyi Medical
Tonglu
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook